Delisting risk
ADGM · NASDAQ · Medical - Devices

Adagio Medical (ADGM)

Catheter-based ablation systems for ventricular tachycardia built on ultra-low-temperature technology.

$0.5250
Pre-market−0.01 (−1.74%)
At close$0.5343(+4.27%)

Something off on this page? Send us feedback.

Next report
Nov 11, 2026
estimated · in 69 days
EPS estimate
−$0.25
Revenue estimate
Fiscal quarter
Q3 FY26

EPSReportedEstimate

May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported−$0.50−$0.35−$0.66−$0.21−$0.31−$0.30−$0.30Pending
Estimate−$0.43−$0.31−$0.36−$0.27−$0.27−$0.25
Surprise−53.5%+32.3%+13.9%−11.1%−11.1%

RevenueReportedEstimate

May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported$0Pending
Estimate
Surprise

History

DateEstimateReportedSurprise
Nov 2026−$0.25
Aug 2026−$0.27−$0.30−11.1%
Aug 2026−$0.27−$0.30−11.1%
May 2026−$0.36−$0.31+13.9%
Mar 2026−$0.31−$0.21+32.3%

The latest year is open to everyone — the 3 quarters behind it read with an account.

Sign in
Nov 2025
Aug 2025
May 2025
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Nov 11, 2026−$0.25
Aug 12, 2026−$0.27−$0.30−11.1%$0−4.0%
Aug 11, 2026−$0.27−$0.30−11.1%−3.4%
May 12, 2026−$0.36−$0.31+13.9%−2.4%
Mar 27, 2026−$0.31−$0.21+32.3%−11.5%

The latest year is open to everyone — the 3 quarters behind it read with an account.

Sign in
Nov 12, 2025
Aug 13, 2025
May 15, 2025